Embremma Injection
By Embremma
Rx
2ml Injection in a Vial

Composition
Eribulin Mesylate(0.5mg/ml)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
September, 2025

liver
When using Embremma Injection, it is important to be cautious if you have liver disease. Patients with liver issues may require adjustments to the dosage of Embremma Injection. It is crucial to consult your doctor regarding the use of Embremma Injection in such situations.

kidney
Embremma Injection requires caution in individuals with kidney disease. Adjusting the dosage may be necessary. Consult your doctor for proper guidance.

alcohol
It is not known if it is safe to drink alcohol while using Embremma Injection. Consult your doctor for more information.

driving
When using Embremma Injection, be cautious while driving as it can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if you experience these symptoms.

pregnancy
Embremma Injection should not be used during pregnancy due to the confirmed risk to the developing baby. In rare life-threatening cases, a doctor may prescribe it if benefits outweigh potential risks. Consult your doctor for advice.

breastfeeding
Embremma Injection is not safe for breastfeeding mothers. Using this medication while breastfeeding can be harmful as it may cause toxicity to the baby.
Habit Forming | No |
Chemical Class | Synthetic analogue of halichondrin B |
Therapeutic Class | - |
Action Class | Antimicrotubule agents- Non Taxanes |
₹21430
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025